arsenic trioxide has been researched along with phenanthrenes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Zhang, ZH; Zhao, WD | 1 |
| Shen, Q; Tang, YH | 1 |
| Chen, Z; Liu, P; Naranmandura, H; Rehman, K; Wang, WW; Xu, S; Zhang, M; Zhang, YF | 1 |
| Cen, JN; Gao, HQ; Hua, HY; Sun, AN; Wu, LL | 1 |
| Lou, Z; Shen, L; Xu, G; Zhang, G | 1 |
| Ban, T; Huo, R; Li, J; Liang, XQ; Tang, HX; Wu, XY; Xue, YD; Xue, ZM; Yu, CX; Zhang, YY; Zhu, H | 1 |
| Huang, JB; Jiang, T; Lou, ZH; Lu, J; Lv, YL; Xu, CY; Yang, DQ; Zhang, GJ; Zhao, ZQ | 1 |
1 review(s) available for arsenic trioxide and phenanthrenes
| Article | Year |
|---|---|
[Molecular mechanism of malignant hematological tumor cell apoptosis induction by active components of traditional Chinese herbs].
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Diterpenes; Drugs, Chinese Herbal; Epoxy Compounds; Hematologic Neoplasms; Humans; Oxides; Phenanthrenes; Quercetin; Tumor Cells, Cultured | 2010 |
6 other study(ies) available for arsenic trioxide and phenanthrenes
| Article | Year |
|---|---|
[Apoptosis of MR2 cells induced by Tanshinone II A combined with arsenic trioxide].
Topics: Abietanes; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Oxides; Phenanthrenes; Tretinoin | 2009 |
Anticancer activity in human multiple myeloma U266 cells: synergy between cryptotanshinone and arsenic trioxide.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Drug Synergism; Humans; Multiple Myeloma; Oxides; Phenanthrenes | 2013 |
Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM‑1 human myelodysplastic syndrome cell line.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Drug Synergism; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Humans; Myelodysplastic Syndromes; Oxides; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2016 |
Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Phenanthrenes; Phosphorylation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
Transient receptor potential melastatin 4 contributes to early-stage endothelial injury induced by arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Cell Survival; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Phenanthrenes; RNA Interference; RNA, Messenger; TRPM Cation Channels; Up-Regulation | 2019 |
Arsenic Trioxide Cooperate Cryptotanshinone Exerts Antitumor Effect by Medicating Macrophage Polarization through Glycolysis.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Carcinoma, Hepatocellular; Cell Differentiation; Cytokines; Drug Combinations; Drug Synergism; Drugs, Chinese Herbal; Glycolysis; Humans; Immunity, Innate; Immunomodulation; Liver Neoplasms; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Phenanthrenes; Th1 Cells | 2022 |